Precipio, Inc. is screened out under 2 exclusion reasons spanning 1 issue category.
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. It is a statement of values.
Precipio, Inc. operates a clinical laboratory business that includes oncology testing services. A review of its business model and public disclosures indicates its operations involve animal testing as part of its diagnostic development and validation processes. The company's reliance on these methods places it within the scope of commercial animal exploitation.
While specific incident reports or enforcement actions against Precipio were not identified in the gathered evidence, the company's sector—clinical diagnostics and biotechnology—is inherently linked to animal-based research. The broader industry context, as highlighted in recent audits, points to systemic animal welfare concerns within U.S. laboratory settings. Precipio's operations contribute to this commercial ecosystem.
This record is flagged due to the company's business activities involving animal exploitation. Further investigation is needed to obtain specific details on the scale, nature, and alternatives explored within Precipio's operations to meet the standard for a detailed, evidence-based narrative.
Precipio, Inc. is a cancer diagnostics and reagent technology company whose business model involves laboratory testing services. The company provides animal models for laboratory testing and offers manufacturing testing services to various industries, indicating that animal testing is an integrated part of its service offerings. This places the company within the scope of contract research organizations (CROs) and diagnostic service providers that commission or conduct animal testing as part of product development or regulatory compliance.
Available evidence from company descriptions and financial filings confirms Precipio's operational involvement in animal model testing, but specific details on the scale, species used, or internal protocols are not publicly disclosed in the gathered sources. The exclusion is based on the company's clear positioning within a testing service sector that relies on animal models.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.